| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | postsynaptic density assembly | 8.47e-06 | 34 | 79 | 4 | GO:0097107 | |
| GeneOntologyBiologicalProcess | postsynaptic specialization assembly | 2.41e-05 | 44 | 79 | 4 | GO:0098698 | |
| GeneOntologyBiologicalProcess | excitatory synapse assembly | 2.88e-05 | 46 | 79 | 4 | GO:1904861 | |
| GeneOntologyBiologicalProcess | postsynapse assembly | 2.90e-05 | 93 | 79 | 5 | GO:0099068 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic density assembly | 6.84e-05 | 21 | 79 | 3 | GO:0099151 | |
| GeneOntologyBiologicalProcess | postsynaptic density organization | 7.23e-05 | 58 | 79 | 4 | GO:0097106 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic specialization assembly | 1.32e-04 | 26 | 79 | 3 | GO:0099150 | |
| GeneOntologyBiologicalProcess | regulation of excitatory synapse assembly | 1.32e-04 | 26 | 79 | 3 | GO:1904889 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic density organization | 1.48e-04 | 27 | 79 | 3 | GO:1905874 | |
| GeneOntologyBiologicalProcess | postsynaptic specialization organization | 1.59e-04 | 71 | 79 | 4 | GO:0099084 | |
| GeneOntologyBiologicalProcess | smooth muscle tissue development | 1.84e-04 | 29 | 79 | 3 | GO:0048745 | |
| Domain | Transket_pyr | 4.87e-04 | 8 | 79 | 2 | SM00861 | |
| Domain | Transket_pyr | 4.87e-04 | 8 | 79 | 2 | PF02779 | |
| Domain | Transketolase-like_Pyr-bd | 4.87e-04 | 8 | 79 | 2 | IPR005475 | |
| Domain | C2-set_2 | 6.92e-04 | 41 | 79 | 3 | PF08205 | |
| Domain | CD80_C2-set | 6.92e-04 | 41 | 79 | 3 | IPR013162 | |
| Domain | Fib_collagen_C | 9.48e-04 | 11 | 79 | 2 | IPR000885 | |
| Domain | COLFI | 9.48e-04 | 11 | 79 | 2 | PF01410 | |
| Domain | NC1_FIB | 9.48e-04 | 11 | 79 | 2 | PS51461 | |
| Domain | Fib_collagen_C | 9.48e-04 | 11 | 79 | 2 | PD002078 | |
| Domain | Tyr_kinase_rcpt_2_CS | 9.48e-04 | 11 | 79 | 2 | IPR002011 | |
| Domain | COLFI | 9.48e-04 | 11 | 79 | 2 | SM00038 | |
| Domain | RECEPTOR_TYR_KIN_II | 1.13e-03 | 12 | 79 | 2 | PS00239 | |
| Domain | THDP-binding | 1.34e-03 | 13 | 79 | 2 | IPR029061 | |
| Domain | - | 1.34e-03 | 13 | 79 | 2 | 3.40.50.970 | |
| Domain | Pkinase_Tyr | 2.19e-03 | 129 | 79 | 4 | PF07714 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 2.79e-03 | 138 | 79 | 4 | IPR001245 | |
| Domain | PAS_fold_3 | 4.22e-03 | 23 | 79 | 2 | IPR013655 | |
| Domain | PAS_3 | 4.22e-03 | 23 | 79 | 2 | PF08447 | |
| Domain | PAS-assoc_C | 4.59e-03 | 24 | 79 | 2 | IPR000700 | |
| Domain | PAS | 4.98e-03 | 25 | 79 | 2 | PF00989 | |
| Domain | PAS_fold | 4.98e-03 | 25 | 79 | 2 | IPR013767 | |
| Domain | PAC | 5.38e-03 | 26 | 79 | 2 | IPR001610 | |
| Domain | PAC | 5.38e-03 | 26 | 79 | 2 | SM00086 | |
| Domain | PAC | 5.38e-03 | 26 | 79 | 2 | PS50113 | |
| Domain | TyrKc | 6.18e-03 | 88 | 79 | 3 | SM00219 | |
| Domain | Tyr_kinase_cat_dom | 6.18e-03 | 88 | 79 | 3 | IPR020635 | |
| Domain | Alkaline_phosphatase_core | 7.59e-03 | 31 | 79 | 2 | IPR017850 | |
| Domain | Alkaline_Pase-like_a/b/a | 7.59e-03 | 31 | 79 | 2 | IPR017849 | |
| Domain | - | 7.59e-03 | 31 | 79 | 2 | 3.40.720.10 | |
| Domain | PAS | 8.07e-03 | 32 | 79 | 2 | SM00091 | |
| Domain | PROTEIN_KINASE_TYR | 8.08e-03 | 97 | 79 | 3 | PS00109 | |
| Domain | Tyr_kinase_AS | 8.08e-03 | 97 | 79 | 3 | IPR008266 | |
| Pubmed | An orphan receptor tyrosine kinase family whose members serve as nonintegrin collagen receptors. | 1.21e-07 | 5 | 81 | 3 | 9659900 | |
| Pubmed | The deubiquitinating protein OTUD6B promotes lung adenocarcinoma progression by stabilizing RIPK1. | 5.36e-06 | 2 | 81 | 2 | 38880876 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 18586678 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 37742185 | ||
| Pubmed | 8.08e-06 | 17 | 81 | 3 | 34184027 | ||
| Pubmed | RELN SORBS2 PTPRD BRD2 PDGFRB JADE2 SUPT5H SIPA1L1 ZNF189 ENPP5 SIM2 RSBN1L B4GALT3 | 8.18e-06 | 1285 | 81 | 13 | 35914814 | |
| Pubmed | 1.26e-05 | 331 | 81 | 7 | 20634891 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 23901112 | ||
| Pubmed | Characterization of Foxp2 and Foxp1 mRNA and protein in the developing and mature brain. | 1.60e-05 | 3 | 81 | 2 | 12687690 | |
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 32652719 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 21044884 | ||
| Pubmed | Expression profile of receptor-type protein tyrosine kinase genes in the human thyroid. | 1.60e-05 | 3 | 81 | 2 | 9492013 | |
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 35848503 | ||
| Pubmed | SENP1 prevents steatohepatitis by suppressing RIPK1-driven apoptosis and inflammation. | 2.08e-05 | 23 | 81 | 3 | 36414671 | |
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 16860615 | ||
| Pubmed | Single-cell transcriptomic analysis of mouse neocortical development. | 4.99e-05 | 170 | 81 | 5 | 30635555 | |
| Pubmed | 5.33e-05 | 5 | 81 | 2 | 9020169 | ||
| Pubmed | Discoidin domain receptor 1 tyrosine kinase has an essential role in mammary gland development. | 5.33e-05 | 5 | 81 | 2 | 11283268 | |
| Pubmed | 5.33e-05 | 5 | 81 | 2 | 12718890 | ||
| Pubmed | 5.33e-05 | 5 | 81 | 2 | 12676565 | ||
| Pubmed | 5.49e-05 | 88 | 81 | 4 | 21491433 | ||
| Pubmed | FARSA COL11A1 LOX UGGT1 AHR PRMT1 UNC45A RSRC2 RSBN1L ITPA NCBP3 RBM17 | 7.68e-05 | 1371 | 81 | 12 | 36244648 | |
| Pubmed | 7.99e-05 | 6 | 81 | 2 | 11025203 | ||
| Pubmed | ColVa1 and ColXIa1 are required for myocardial morphogenesis and heart valve development. | 7.99e-05 | 6 | 81 | 2 | 17029294 | |
| Pubmed | 7.99e-05 | 6 | 81 | 2 | 22351047 | ||
| Pubmed | The discoidin domain receptor tyrosine kinases are activated by collagen. | 7.99e-05 | 6 | 81 | 2 | 9659899 | |
| Pubmed | 7.99e-05 | 6 | 81 | 2 | 22718755 | ||
| Pubmed | The timing of cortical neurogenesis is encoded within lineages of individual progenitor cells. | 7.99e-05 | 6 | 81 | 2 | 16680166 | |
| Pubmed | 9.78e-05 | 196 | 81 | 5 | 21862448 | ||
| Pubmed | 1.12e-04 | 7 | 81 | 2 | 22306017 | ||
| Pubmed | 1.13e-04 | 40 | 81 | 3 | 30898150 | ||
| Pubmed | Extracellular-matrix gene expression during mouse submandibular gland development. | 1.49e-04 | 8 | 81 | 2 | 9382709 | |
| Pubmed | 1.49e-04 | 8 | 81 | 2 | 9164858 | ||
| Pubmed | 1.49e-04 | 8 | 81 | 2 | 18816857 | ||
| Pubmed | 1.49e-04 | 8 | 81 | 2 | 11782478 | ||
| Pubmed | 1.91e-04 | 9 | 81 | 2 | 23931996 | ||
| Pubmed | 1.91e-04 | 9 | 81 | 2 | 9704006 | ||
| Pubmed | 1.91e-04 | 9 | 81 | 2 | 25715693 | ||
| Pubmed | Cell cycle during neuronal migration and neocortical lamination. | 1.91e-04 | 9 | 81 | 2 | 33448039 | |
| Pubmed | 1.91e-04 | 9 | 81 | 2 | 14704420 | ||
| Pubmed | Projections and interconnections of genetically defined serotonin neurons in mice. | 1.91e-04 | 9 | 81 | 2 | 22151329 | |
| Pubmed | 1.91e-04 | 9 | 81 | 2 | 16387638 | ||
| Pubmed | Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition. | 2.38e-04 | 372 | 81 | 6 | 22939624 | |
| Pubmed | 2.38e-04 | 10 | 81 | 2 | 29127326 | ||
| Pubmed | Kif14 mutation causes severe brain malformation and hypomyelination. | 2.38e-04 | 10 | 81 | 2 | 23308235 | |
| Pubmed | 2.38e-04 | 10 | 81 | 2 | 22479190 | ||
| Pubmed | 2.38e-04 | 10 | 81 | 2 | 2446864 | ||
| Pubmed | 2.38e-04 | 10 | 81 | 2 | 17507397 | ||
| Pubmed | 2.38e-04 | 10 | 81 | 2 | 19389366 | ||
| Pubmed | 2.38e-04 | 10 | 81 | 2 | 21768377 | ||
| Pubmed | 2.38e-04 | 10 | 81 | 2 | 19858780 | ||
| Pubmed | Myelin suppresses axon regeneration by PIR-B/SHP-mediated inhibition of Trk activity. | 2.91e-04 | 11 | 81 | 2 | 21364532 | |
| Pubmed | Active intermixing of indirect and direct neurons builds the striatal mosaic. | 2.91e-04 | 11 | 81 | 2 | 30413696 | |
| Pubmed | 2.91e-04 | 11 | 81 | 2 | 27909010 | ||
| Pubmed | 3.48e-04 | 12 | 81 | 2 | 32780108 | ||
| Pubmed | A role for mDia, a Rho-regulated actin nucleator, in tangential migration of interneuron precursors. | 3.48e-04 | 12 | 81 | 2 | 22246438 | |
| Pubmed | 3.48e-04 | 12 | 81 | 2 | 30670377 | ||
| Pubmed | Identification of phagocytosis regulators using magnetic genome-wide CRISPR screens. | 3.57e-04 | 143 | 81 | 4 | 30397336 | |
| Pubmed | ELOF1 is a transcription-coupled DNA repair factor that directs RNA polymerase II ubiquitylation. | 3.60e-04 | 59 | 81 | 3 | 34108663 | |
| Pubmed | Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-kappaB signalling. | 3.95e-04 | 265 | 81 | 5 | 19240061 | |
| Pubmed | 4.11e-04 | 13 | 81 | 2 | 26637354 | ||
| Pubmed | Novel markers reveal subpopulations of subplate neurons in the murine cerebral cortex. | 4.11e-04 | 13 | 81 | 2 | 19008461 | |
| Pubmed | Opposing roles of hepatic stellate cell subpopulations in hepatocarcinogenesis. | 4.11e-04 | 13 | 81 | 2 | 36198802 | |
| Pubmed | 4.11e-04 | 13 | 81 | 2 | 11863365 | ||
| Pubmed | 4.79e-04 | 14 | 81 | 2 | 22821687 | ||
| Pubmed | 4.79e-04 | 14 | 81 | 2 | 15964824 | ||
| Pubmed | Membrane-type MMPs are indispensable for placental labyrinth formation and development. | 4.79e-04 | 14 | 81 | 2 | 20858856 | |
| Pubmed | 4.83e-04 | 277 | 81 | 5 | 30745168 | ||
| Pubmed | 5.17e-04 | 1215 | 81 | 10 | 15146197 | ||
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | TXNRD1 OSBP FARSA SUPT5H OTUD6B UGGT1 WRNIP1 SHMT1 PRMT1 UNC45A PAIP1 | 5.46e-04 | 1455 | 81 | 11 | 22863883 |
| Pubmed | Collagen II is essential for the removal of the notochord and the formation of intervertebral discs. | 5.52e-04 | 15 | 81 | 2 | 9832566 | |
| Pubmed | 5.52e-04 | 15 | 81 | 2 | 23727838 | ||
| Pubmed | 5.52e-04 | 15 | 81 | 2 | 24115331 | ||
| Pubmed | Directional neuronal migration is impaired in mice lacking adenomatous polyposis coli 2. | 5.52e-04 | 15 | 81 | 2 | 22573669 | |
| Pubmed | 5.52e-04 | 15 | 81 | 2 | 29901792 | ||
| Pubmed | Binding of OTULIN to the PUB domain of HOIP controls NF-κB signaling. | 5.52e-04 | 15 | 81 | 2 | 24726327 | |
| Pubmed | 6.27e-04 | 622 | 81 | 7 | 14574404 | ||
| Pubmed | 6.29e-04 | 16 | 81 | 2 | 25053428 | ||
| Pubmed | 6.29e-04 | 16 | 81 | 2 | 26235615 | ||
| Pubmed | 6.29e-04 | 16 | 81 | 2 | 36092713 | ||
| Pubmed | 6.29e-04 | 16 | 81 | 2 | 38750507 | ||
| Pubmed | 6.29e-04 | 16 | 81 | 2 | 14758363 | ||
| Pubmed | 6.29e-04 | 16 | 81 | 2 | 24804215 | ||
| Pubmed | 7.12e-04 | 17 | 81 | 2 | 21512159 | ||
| Pubmed | 7.12e-04 | 17 | 81 | 2 | 37590085 | ||
| Pubmed | Nova2 regulates neuronal migration through an RNA switch in disabled-1 signaling. | 7.12e-04 | 17 | 81 | 2 | 20620871 | |
| Pubmed | 7.12e-04 | 17 | 81 | 2 | 22573622 | ||
| Pubmed | 7.12e-04 | 17 | 81 | 2 | 21315259 | ||
| Pubmed | PITX2 insufficiency leads to atrial electrical and structural remodeling linked to arrhythmogenesis. | 8.00e-04 | 18 | 81 | 2 | 21511879 | |
| Pubmed | Muscle composition is regulated by a Lox-TGFβ feedback loop. | 8.93e-04 | 19 | 81 | 2 | 25715398 | |
| Pubmed | 8.93e-04 | 19 | 81 | 2 | 19474196 | ||
| Pubmed | Pericytes are required for blood-brain barrier integrity during embryogenesis. | 8.93e-04 | 19 | 81 | 2 | 20944625 | |
| Pubmed | 8.93e-04 | 19 | 81 | 2 | 25249461 | ||
| Pubmed | 8.93e-04 | 19 | 81 | 2 | 21666133 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | 9.27e-04 | 1082 | 81 | 9 | 38697112 | |
| Pubmed | 9.78e-04 | 83 | 81 | 3 | 11114734 | ||
| Pubmed | 9.91e-04 | 20 | 81 | 2 | 21689717 | ||
| Pubmed | ERK1 and ERK2 are required for radial glial maintenance and cortical lamination. | 1.09e-03 | 21 | 81 | 2 | 20825492 | |
| Pubmed | 1.09e-03 | 21 | 81 | 2 | 23404109 | ||
| Pubmed | Ubiquitin-specific protease 7 sustains DNA damage response and promotes cervical carcinogenesis. | 1.09e-03 | 21 | 81 | 2 | 30179224 | |
| Interaction | TIGIT interactions | 3.22e-06 | 26 | 80 | 4 | int:TIGIT | |
| Cytoband | 1q21-q23 | 2.37e-04 | 13 | 81 | 2 | 1q21-q23 | |
| Cytoband | 6p25.2 | 6.94e-04 | 22 | 81 | 2 | 6p25.2 | |
| Cytoband | 8q21.3 | 1.21e-03 | 29 | 81 | 2 | 8q21.3 | |
| GeneFamily | C2-set domain containing|Immunoglobulin like domain containing|Scavenger receptors | 1.52e-04 | 40 | 47 | 3 | 592 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 1.52e-04 | 40 | 47 | 3 | 321 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 8.02e-04 | 161 | 47 | 4 | 593 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 3.47e-03 | 394 | 47 | 5 | 471 | |
| Coexpression | HALLMARK_UV_RESPONSE_DN | 5.73e-06 | 144 | 81 | 6 | M5942 | |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | TXNRD1 ILRUN RHOQ OSBP RELN BRD2 LOX AHR KLF3 ACVR2A SIM2 RSRC2 | 8.12e-06 | 822 | 81 | 12 | M6782 |
| Coexpression | GSE6259_33D1_POS_DC_VS_BCELL_UP | 8.74e-06 | 155 | 81 | 6 | M6751 | |
| Coexpression | DING_LUNG_CANCER_BY_MUTATION_RATE | 3.12e-05 | 20 | 81 | 3 | M1189 | |
| Coexpression | GSE339_CD8POS_VS_CD4CD8DN_DC_IN_CULTURE_DN | 3.69e-05 | 200 | 81 | 6 | M5128 | |
| Coexpression | GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_30H_UP | 3.69e-05 | 200 | 81 | 6 | M9649 | |
| Coexpression | CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN | 3.78e-05 | 407 | 81 | 8 | M2214 | |
| Coexpression | ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE | 4.67e-05 | 64 | 81 | 4 | M2572 | |
| Coexpression | DANG_REGULATED_BY_MYC_UP | 5.93e-05 | 68 | 81 | 4 | M18501 | |
| Coexpression | LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2 | 6.43e-05 | 221 | 81 | 6 | M39222 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.31e-06 | 190 | 81 | 6 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.39e-06 | 192 | 81 | 6 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG|World / Primary Cells by Cluster | 1.61e-06 | 197 | 81 | 6 | 61749ccafeb938c310cff1de5ff924a1c794325a | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG-25|World / Primary Cells by Cluster | 1.61e-06 | 197 | 81 | 6 | 9d4ffa3680f92c91d0a081f9a8ec5ebfec6bdcf6 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_myocytic|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.66e-06 | 198 | 81 | 6 | 55d2ed345101bec4b73f1242ba8c4d73073b7e88 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteoblast_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.66e-06 | 198 | 81 | 6 | bc9c9f2c87282b5ef8514773e065d2a6b5dde338 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_myocytic-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.66e-06 | 198 | 81 | 6 | 8602a518b5913625b1dd3cbc3c7e6efde0d5d942 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.71e-06 | 199 | 81 | 6 | 7b1b3b108d817fb3b50a710c3146b30bcf9c2f6b | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.71e-06 | 199 | 81 | 6 | f2ad641f36c577ff7019e88ad6b73ed7e46d8c74 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.44e-06 | 155 | 81 | 5 | 77fdae85d36efb776db977eb424b32487ef222e4 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.13e-05 | 161 | 81 | 5 | 347edb0de10850b7d16c40945751033289289c9b | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-05 | 168 | 81 | 5 | 0e8b0e6399c6c82c9c0e546f7316f902de0765d3 | |
| ToppCell | E17.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.47e-05 | 170 | 81 | 5 | 7fa022471e14ac8a3bc147c793368a4d56a8e591 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.60e-05 | 173 | 81 | 5 | 922356a5b4c84607318ac24d7caa2e235b72b066 | |
| ToppCell | wk_15-18-Mesenchymal-Chondrocyte-Resting_chondrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.79e-05 | 177 | 81 | 5 | b01d7a6a78169962123ddfb0bb588f51d138ad02 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-6|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.84e-05 | 178 | 81 | 5 | 142879e9393e721f9b05a6bb46995c9d6d713c95 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-early_osteoblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.84e-05 | 178 | 81 | 5 | e32f5ed7a492edfa7073416008b1fcfae6b854ad | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_vein-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.94e-05 | 180 | 81 | 5 | 27e8bbee388e64dd79d70b160b76d45b1f398006 | |
| ToppCell | wk_15-18-Mesenchymal-Chondrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.99e-05 | 181 | 81 | 5 | 8950844b3e65c7028d80da5787ae2ce509c3d52d | |
| ToppCell | 21-Trachea-Mesenchymal-Mesenchyme_SERPINF1-high|Trachea / Age, Tissue, Lineage and Cell class | 2.05e-05 | 182 | 81 | 5 | 354dcdb01360597f68c4fe157a682aee1c0b8bb1 | |
| ToppCell | wk_08-11-Mesenchymal-Chondrocyte-Resting_chondrocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.05e-05 | 182 | 81 | 5 | 00a148b1e499bf16325491536d187d4dd6b70c06 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L2-3_LINC00507_RPL9P17|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.10e-05 | 183 | 81 | 5 | 1645d4a55cd8c22d6eb47fc5c6b1e576c454f111 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.16e-05 | 184 | 81 | 5 | 30fddbc9696476d4d7f08e53f84ea994a4ed873a | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L2-3_LINC00507_RPL9P17|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.16e-05 | 184 | 81 | 5 | 96926efa220f03d0787322c9519bb9e8f64f74d0 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-osteochondral_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.39e-05 | 188 | 81 | 5 | ed92cddf47defea2f904d36c7ae05ffa323349a9 | |
| ToppCell | Mesenchymal-chondrocyte|World / Lineage, Cell type, age group and donor | 2.39e-05 | 188 | 81 | 5 | 7b1e3f8a941eaa68e89c562129a92314642eec66 | |
| ToppCell | Mesenchymal_cells-Osteoblasts|World / Lineage and Cell class | 2.39e-05 | 188 | 81 | 5 | 89f7f5a51be7e046a63e2413f86c521ae4b6718f | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.45e-05 | 189 | 81 | 5 | a153b83314cf52808f685296cff8c95af3f4983d | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.45e-05 | 189 | 81 | 5 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.52e-05 | 190 | 81 | 5 | 6c7e1086c0a274cd5527c3104106e372811c9905 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.52e-05 | 190 | 81 | 5 | 841cd55861b43578d704418b9bc0af2e8b88323a | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.52e-05 | 190 | 81 | 5 | d60395739458d7f47a3350ade751fe3819500320 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.58e-05 | 191 | 81 | 5 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.65e-05 | 192 | 81 | 5 | 6f4ef24dab544681304b7f8a9dc073e7edaa4cf5 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.65e-05 | 192 | 81 | 5 | dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.65e-05 | 192 | 81 | 5 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.65e-05 | 192 | 81 | 5 | ee085e04d5dcfb657522484ed20b8c1ddeccfe0c | |
| ToppCell | ASK452-Endothelial-Lymphatic|Endothelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.85e-05 | 195 | 81 | 5 | 20f492299a684ac1b7dd1bbc36a533cd6f9a1c93 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_myocytic-stroma-myofibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.85e-05 | 195 | 81 | 5 | 30ed961151b8b1f6ce37f06c9a061519f01c2864 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.92e-05 | 196 | 81 | 5 | f374cb3ec31c6eef2cef9e07547bfd1e380553af | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.92e-05 | 196 | 81 | 5 | 671c380b58d7f634b4fbec38c357d357ea4f3535 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.92e-05 | 196 | 81 | 5 | 545d2e4469924d333e3f655f559c899fa1260196 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma-osteoblast_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.99e-05 | 197 | 81 | 5 | 2f72fd9a5b6d62c24a95ed2246194ea7458c0f12 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.99e-05 | 197 | 81 | 5 | 63b63c6b2f842adb87bc83222ff86796bd9b58f6 | |
| ToppCell | 5'-Adult-Appendix-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.99e-05 | 197 | 81 | 5 | 789c97ca9d1e28df3353140046047f11fbccc1d0 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.99e-05 | 197 | 81 | 5 | fb50903b87498b400c8e16e6a561b6d9458e5d97 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-05 | 197 | 81 | 5 | cfd4cc5fb8d7a60dd5c0d2a1a7bad7ba38c19d40 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.07e-05 | 198 | 81 | 5 | 9541d68a1a6247dbd7161a62644eea6527c2c8ff | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteoblast_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.07e-05 | 198 | 81 | 5 | 9d61483b0decac2fe90045b3474843360b2c49b3 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-early_osteoblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.07e-05 | 198 | 81 | 5 | 6a539d3b47bd2d4a7ad5c67cad23facffc0ac45f | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.22e-05 | 200 | 81 | 5 | 780d47f8eff630020dfae32218de495a7e9dbad6 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.22e-05 | 200 | 81 | 5 | a4ec0e80f5422b91b85264a9bb74568dd577e285 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.22e-05 | 200 | 81 | 5 | 28dd127787a57276253548d1f030814b1af64481 | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-LTK---L2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.22e-05 | 200 | 81 | 5 | 6ebdae4438bc64c6620416f64a7e22fbca2664bf | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-LTK-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.22e-05 | 200 | 81 | 5 | 081ca331b56f85167acfc73af9d2e91f398f8c4d | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.22e-05 | 200 | 81 | 5 | 3c898e81444b001835c3f1bbc68183078701b135 | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-LTK--|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.22e-05 | 200 | 81 | 5 | 66e2f3e2e9063f17b47621120eb6009405f69e7e | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Macroglial-Astrocyte|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 3.22e-05 | 200 | 81 | 5 | 7205e742ad796d548761839d92a4794ee8f17629 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.22e-05 | 200 | 81 | 5 | 3eca8ffeb41b664fbdbbd70b375c5d953503ab29 | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-LTK|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.22e-05 | 200 | 81 | 5 | 940892bea41fde567f138a896d151acccef03a6a | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Macroglial|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 3.22e-05 | 200 | 81 | 5 | 25b573f4427ecafe050ca90bea459f1b25b451cf | |
| ToppCell | RV-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 7.29e-05 | 122 | 81 | 4 | 1cb1dd03b2aaedbe04f3ed907568c3b7f54767b3 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.08e-04 | 135 | 81 | 4 | 3351e8b9e417397c5fa9f856184ff24ce1a27242 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_and_Lobular_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.58e-04 | 149 | 81 | 4 | 3904f8ce9078de238600ceceee0116af52256a1c | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.75e-04 | 153 | 81 | 4 | 61fe71e32fc9c8cad875bc087aad0b0ff680bf45 | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast-FB-1|E18.5-samps / Age Group, Lineage, Cell class and subclass | 2.02e-04 | 159 | 81 | 4 | b4bc888e978b1b577721b891b0af6ba9a1607044 | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.22e-04 | 163 | 81 | 4 | 0ab043b68e8739adcedda01165a3758cd0d22728 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l32-30|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.28e-04 | 164 | 81 | 4 | 3caf4cdaa0164907893fea61e251fd8b5fa926e4 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.33e-04 | 165 | 81 | 4 | 4e13fccd32029e2879e85f8966e582a46c09e4aa | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.44e-04 | 167 | 81 | 4 | fe3338f99f94c0dac37e3d649dfdce82e4a56022 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-H-|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.49e-04 | 168 | 81 | 4 | b5d74500bdac0d680ce7eb7afa0b867b8d85e6a4 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.49e-04 | 168 | 81 | 4 | fa0d251693935116adf633d02b7ec4a295100865 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-H|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.49e-04 | 168 | 81 | 4 | 838ce47d4958ba12047882f97925eddd02f081c7 | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast-tracheal_fibroblast|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.55e-04 | 169 | 81 | 4 | 58e22f9119240664515fe91ca53812611a8f17d6 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.61e-04 | 170 | 81 | 4 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.61e-04 | 170 | 81 | 4 | 8e1f757ed62218c0fb6525f49d142dd2cd29acf9 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.61e-04 | 170 | 81 | 4 | cb1ed6bd409ee1cf11be0d5e7cdcffe2ab220d38 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.61e-04 | 170 | 81 | 4 | 67d7e1da3ebd2d14cb2e67799e94d655027ed5c4 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.61e-04 | 170 | 81 | 4 | da4fb1e186e9bec6bba0b25f2a0e68f9e11c6017 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_NK-NK_CD16|GI_small-bowel / Manually curated celltypes from each tissue | 2.67e-04 | 171 | 81 | 4 | 1ee505b91f15191d294a5d491ecdf154c08b8622 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_LCN15|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.67e-04 | 171 | 81 | 4 | 9e00c8191ca9d52151a49baf39f8581cb176fb76 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.67e-04 | 171 | 81 | 4 | f5014e3c387fe3118944af392abe10d6b9b0abab | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-plasmacytoid_dendritic_cell-plasmacytoid_dendritic|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.67e-04 | 171 | 81 | 4 | 2dfed6e9ac89adb2501a1a5e1ca895f49190562d | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-plasmacytoid_dendritic_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.67e-04 | 171 | 81 | 4 | 2aaae0229c3a13d0275a03a3d576db650c2bf2c0 | |
| ToppCell | E15.5-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_vein|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.67e-04 | 171 | 81 | 4 | 3112d15f2a28cf4a71992db4971d960716dc1264 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.73e-04 | 172 | 81 | 4 | 1ef243bce63d841c25e4b74d029d1377f84bcc3d | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.73e-04 | 172 | 81 | 4 | ab1c81be29f93ca8920c6ab5ab92f497a9256d3f | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-Plasmacytoid_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.79e-04 | 173 | 81 | 4 | 8fb32a9f2dbec16de840d55b4db7e7718f5a2a7a | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-plasmacytoid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.79e-04 | 173 | 81 | 4 | f663571aaae2365660a8b526c355f4bd1a124a74 | |
| ToppCell | Caecum-Macrophage-LYVE1_Macrophage|Macrophage / Region, Cell class and subclass | 2.82e-04 | 70 | 81 | 3 | 05f8fc648641b9db50c2ae20d6246b52869957cf | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.85e-04 | 174 | 81 | 4 | b3cd22e717d178269e6d5bd5ed7b2d945cd8ea25 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_LCN15|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.85e-04 | 174 | 81 | 4 | 2947e5906b172d149412fa4e77476fce4ea695d2 | |
| ToppCell | wk_15-18-Mesenchymal-Chondrocyte-intermediate_chondrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.91e-04 | 175 | 81 | 4 | a84965d28438a4228d841b357c2cd75cf4b59a63 | |
| ToppCell | COVID-19-Heart-CM_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.98e-04 | 176 | 81 | 4 | 9df7a124ebafb0087da0cda133a394275d7bed81 | |
| ToppCell | ASK452-Endothelial-Lymphatic|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.98e-04 | 176 | 81 | 4 | b4d280ecc07701d526f50d44c45ea91b3eeb00b1 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.04e-04 | 177 | 81 | 4 | 8220cc2fc0ee8764a67a3be51d75248be2453040 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.04e-04 | 177 | 81 | 4 | 4c069f0d044a96118090b85ca592a21d6b5d9399 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.04e-04 | 177 | 81 | 4 | 7617270f49cd6b7ba66db72d20560cee985012b2 | |
| ToppCell | -Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 3.17e-04 | 179 | 81 | 4 | 10fadbaa1b6d21cbf9f354d717cc4c225619f4fd | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_8|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.17e-04 | 179 | 81 | 4 | 163f5430d72ea0c1b239ea5d21e53be536636d3d | |
| Disease | interleukin-6 measurement, response to cytokine | 6.90e-06 | 2 | 78 | 2 | EFO_0004810, GO_0034097 | |
| Disease | interleukin-6 measurement, response to corticosteroid, response to cytokine | 6.90e-06 | 2 | 78 | 2 | EFO_0004810, GO_0031960, GO_0034097 | |
| Disease | Weight Gain | 1.58e-04 | 102 | 78 | 4 | C0043094 | |
| Disease | coiled-coil domain-containing protein 80 measurement | 1.91e-04 | 8 | 78 | 2 | EFO_0020268 | |
| Disease | disease recurrence, unipolar depression, bipolar disorder, schizophrenia | 1.91e-04 | 8 | 78 | 2 | EFO_0003761, EFO_0004952, MONDO_0004985, MONDO_0005090 | |
| Disease | Gastric Adenocarcinoma | 2.33e-04 | 45 | 78 | 3 | C0278701 | |
| Disease | Ehlers-Danlos syndrome (is_implicated_in) | 2.45e-04 | 9 | 78 | 2 | DOID:13359 (is_implicated_in) | |
| Disease | Aortic Valve Insufficiency | 3.74e-04 | 11 | 78 | 2 | C0003504 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 3.78e-04 | 53 | 78 | 3 | C4707243 | |
| Disease | Liver Cirrhosis, Experimental | 1.01e-03 | 774 | 78 | 8 | C0023893 | |
| Disease | QRS duration | 1.18e-03 | 298 | 78 | 5 | EFO_0005055 | |
| Disease | unipolar depression, bipolar disorder, schizophrenia | 1.27e-03 | 20 | 78 | 2 | EFO_0003761, MONDO_0004985, MONDO_0005090 | |
| Disease | Cleft Palate | 1.31e-03 | 81 | 78 | 3 | C0008925 | |
| Disease | short-term memory | 1.40e-03 | 83 | 78 | 3 | EFO_0004335 | |
| Disease | Back pain | 1.61e-03 | 87 | 78 | 3 | HP_0003418 | |
| Disease | autism spectrum disorder, schizophrenia | 1.77e-03 | 327 | 78 | 5 | EFO_0003756, MONDO_0005090 | |
| Disease | Left Ventricular Hypertrophy | 1.99e-03 | 25 | 78 | 2 | C0149721 | |
| Disease | Adenocarcinoma of lung (disorder) | 2.20e-03 | 206 | 78 | 4 | C0152013 | |
| Disease | Schizophrenia | 2.30e-03 | 883 | 78 | 8 | C0036341 | |
| Disease | triglyceride measurement, response to escitalopram, response to citalopram | 2.32e-03 | 27 | 78 | 2 | EFO_0004530, EFO_0006329, EFO_0007871 | |
| Disease | susceptibility to rheumatic fever measurement | 2.49e-03 | 28 | 78 | 2 | EFO_0008416 | |
| Disease | glucose metabolism disease (implicated_via_orthology) | 2.49e-03 | 28 | 78 | 2 | DOID:4194 (implicated_via_orthology) | |
| Disease | Liver Cirrhosis | 2.60e-03 | 103 | 78 | 3 | C0023890 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PYKSEMDSMPYTQNF | 686 | P35869 | |
| VSYKNYEFFLPDNME | 86 | P16118 | |
| TPDQYLKMNGFPNEY | 241 | O60512 | |
| NEKFSYFPEMEVTQP | 111 | P27037 | |
| KPTNTQAYSGDYMEP | 536 | Q08345 | |
| NPMNPKKYLGSFYTD | 251 | Q8TDX5 | |
| PDYYENNVHKMQLPF | 266 | Q9H9F9 | |
| NELDEPFYTNPIMYK | 436 | Q96HY7 | |
| PNNPEYSDLMESVTY | 681 | Q6DHV5 | |
| KPNAEDMTSKDYYFD | 41 | Q99873 | |
| VYEPNPFSKYLEDNS | 351 | Q5VWP3 | |
| QEAMDPVSVSYPSNY | 11 | P57682 | |
| SNMSDQGPYNEYEPT | 476 | O43300 | |
| LQFEGYASMDVKYPP | 226 | P20916 | |
| YYNPTLNDSAMPESE | 301 | Q8N387 | |
| MSNSDYLPDYPLNSD | 1 | Q6ZVZ8 | |
| EMSYDNNPFIKTLYD | 1741 | P12107 | |
| MKIPDSYQLSPDDYY | 61 | Q9NQC1 | |
| ANPIYAGDYPQVMKD | 291 | Q6UWM7 | |
| PTHYMPYNESVSFED | 151 | Q9UJA9 | |
| PMSSEIAPNYEFYKN | 486 | O15409 | |
| MSTQDVFSYFKEYPP | 136 | Q53F19 | |
| DYKEEYNTTLPQFMP | 1386 | O60449 | |
| DEMQPYASYTEKNNP | 286 | Q8TD46 | |
| KSGDFQMSPYAEYPK | 1286 | Q9ULI3 | |
| YKVEYPIMYSTDPEN | 36 | O14880 | |
| LPKNAENMYYFSELA | 686 | P22059 | |
| PENDPNYFMNEPTFY | 391 | Q9H074 | |
| PQNFYEKPAFDYPMN | 1236 | P78509 | |
| LDENNQSPYFTMPSY | 386 | Q96QU1 | |
| PNTGDMYTPEEFQKY | 201 | Q8N6M0 | |
| AYYDFESPNISVPSM | 61 | Q9H6K1 | |
| PPEYMLELYNKFATD | 81 | O95393 | |
| QPYNFELSKDMRPFF | 16 | Q9HB03 | |
| MGYFLPDDYKFSVPN | 821 | Q8ND61 | |
| MVGDDPYNPYKYSDD | 166 | P28300 | |
| IGMIQKFPYDDPTYD | 86 | Q8WV07 | |
| VNPEYFSASDMYVPD | 956 | P14616 | |
| QPDGYEQTYAEMPKA | 156 | Q9BY32 | |
| FAPYYGDEPMDFKIN | 1216 | P02461 | |
| DPDLSDMKNNEPYDY | 381 | Q6YP21 | |
| IESSNYMAPYDNYVP | 766 | P09619 | |
| PENYNSAMPFKILYD | 1041 | P23468 | |
| FFESMPYKVNPDTGY | 166 | P34896 | |
| YNENPKGYMLDDADS | 916 | Q92834 | |
| DYFSFNFPNSPVKME | 416 | Q6PCB5 | |
| LMSYANDAFPEEYVP | 26 | P17081 | |
| SYYNPAAVNPMKFAE | 316 | Q7L4I2 | |
| KPAYNPYTEPSMEVF | 406 | Q9Y285 | |
| SIHEYPKYQAEFPMS | 371 | O75019 | |
| QMTPSTQEFYVDYKP | 471 | Q86VH5 | |
| EPQMYAPSSTASYFE | 96 | P48378 | |
| YQAYQPPAMKYSDSV | 391 | O75603 | |
| MSAYPKSYNPFDDDG | 1 | O95721 | |
| EKPDEMKENGSPYNY | 521 | O43166 | |
| YPPQQYSSFQMDKLE | 386 | Q14190 | |
| TPAMYNTDQFSPYAA | 881 | O00267 | |
| YYMAPEHLNDVNAKP | 191 | Q13546 | |
| NFKMPFPIDQDFYVS | 391 | P51688 | |
| ASAYPSKYSEMFPQI | 341 | Q9NP91 | |
| PDDDTDMYNTPYTYN | 111 | O94875 | |
| MFSNCYKYNPPDHDV | 421 | P25440 | |
| MNGPEDLPKSYDYDL | 151 | Q16881 | |
| KTYPYNETKESFDPN | 426 | O75820 | |
| PFYQYMETDNFKLPN | 266 | P51512 | |
| LADEYDPMFPNDYEK | 96 | Q96I25 | |
| NTYNKFPYPTMSEIT | 301 | Q9UKY1 | |
| DPMGPAESLFKESYY | 176 | P19623 | |
| TPISYAEQYPKFESM | 526 | Q5HYM0 | |
| KYNPMYSEPVDQEYL | 636 | Q96S55 | |
| VPDFNKMYELYDPCT | 66 | P83876 | |
| DHPQGTEPDMYKYDA | 681 | O60602 | |
| YDPKDKSYNNMAFET | 601 | Q1EHB4 | |
| YLEDMKTYFGAEPQP | 126 | P48595 | |
| FFYIMRYKQSDPENP | 61 | P51854 | |
| CTNSYDYEEPDPKMV | 596 | Q9H3U1 | |
| SPTFKEFIPYMANEY | 1296 | Q9NYU2 | |
| PYDMYILNASNPDTA | 66 | Q6SJ96 | |
| KENYPDYMPSNIFSD | 3151 | Q5THJ4 | |
| YMNTSVQEPPLDYSF | 6 | Q96E66 | |
| GDYFAKNYIPPSDMQ | 436 | Q9NQS3 |